Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

KORU Medical Systems, Inc. Director's Dealing 2020

Dec 17, 2020

33778_dirs_2020-12-17_b399ceaa-62a5-4e88-abe1-08c427f00061.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPRO MED SYSTEMS INC (KRMD)
CIK: 0000704440
Period of Report: 2020-12-15

Reporting Person: Marques Manuel A (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-15 Common Stock F 26920 $5.535 Disposed 243080 Direct
2020-12-15 Common Stock M 62500 $0.50 Acquired 305580 Direct
2020-12-15 Common Stock M 75000 $1.57 Acquired 380580 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-15 Options to Purchase Common Stock $0.50 M 62500 Disposed 2022-10-10 Common Stock (62500) Direct
2020-12-15 Options to Purchase Common Stock $1.57 M 75000 Disposed 2029-01-28 Common Stock (75000) Direct

Footnotes

F1: Represents the payment of the exercise price of stock options through the delivery of previously owned shares to the issuer.

F2: The price is equal to the Fair Market Value of the Common Stock, as defined in the stock option award agreements, and is used to determine the value of the shares delivered to the issuer in payment of the exercise price.

F3: Options vest in 15,625 increments quarterly. Date Excercisable 01/11/2018-10/11/2020.